Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline

Novel antimicrobial agents, approved for clinical use in past years, represent potential treatment options for various infections. In this review, we summarize the most important medical and microbiological features of three recently approved fluoroquinolones, namely delafloxacin, finafloxacin, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocsis, Béla, Gulyás, Dániel, Szabó, Dóra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698389/
https://www.ncbi.nlm.nih.gov/pubmed/34943718
http://dx.doi.org/10.3390/antibiotics10121506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698389/
https://www.ncbi.nlm.nih.gov/pubmed/34943718
http://dx.doi.org/10.3390/antibiotics10121506

Ejemplares similares